throbber

`
`DEPARTMENT OF HEALTH & HUMAN SERVICES
`
`
`
`
`
`
`
`
`Public Health Service
`Food and Drug Administration
`Rockville, MD 20857
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`NDA 21-372/S-002
`
`
`Helsinn Healthcare SA.
`Attention: Ms. Carol Anding – (US Agent-MGI Pharma, Inc.)
`5775 West Old Shakopee Road, Suite 1000
`Bloomington, MN 55437
`
`Dear Ms. Anding:
`
`Please refer to your supplemental new drug application dated April 14, 2004, received April 16, 2004,
`submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act for Aloxi™
`(palonosetron hydrochloride) Injection, 0.25 mg/5 mL.
`
`We acknowledge receipt of your submissions dated January 5, January 31, and June 24, 2005.
`
`We also acknowledge the June 28, 2005 teleconference between you and the Division and your June
`28, 2005 submission containing the agreed-upon final Patient Package Insert (PPI) text incorporating
`the agreed upon changes in your June 24, 2005 submission, and the additional revision discussed in the
`June 28, 2005 teleconference.
`
`Your submission of January 5, 2005 constituted a complete response to our October 15, 2004 action
`letter.
`
`This supplemental new drug application provides for the addition of a PPI to the labeling.
`
`We completed our review of this application, as amended. This application is approved, effective on
`the date of this letter, for use as recommended in the agreed-upon labeling text.
`
`The final printed labeling (FPL) must be identical to the enclosed labeling text for the draft patient
`package insert (identified as “28 JUNE 2005 FINAL VERSION”), submitted June 28, 2005.
`
`Please submit an electronic version of the FPL according to the guidance for industry titled Providing
`Regulatory Submissions in Electronic Format - NDA. Alternatively, you may submit 20 paper copies
`of the FPL as soon as it is available but no more than 30 days after it is printed. Individually mount 15
`of the copies on heavy-weight paper or similar material. For administrative purposes, designate this
`Submission "FPL for approved supplement NDA 21-372/S-002. Approval of this submission by
`FDA is not required before the labeling is used.
`
`
`
`
`
`
`

`

`NDA 21-372/S-002
`Page 2
`
`If you issue a letter communicating important information about this drug product (i.e., a “Dear Health
`Care Professional” letter), we request that you submit a copy of the letter to this NDA and a copy to
`the following address:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`We remind you that you must comply with reporting requirements for an approved
`NDA (21 CFR 314.80 and 314.81).
`
`If you have any questions, call Betsy Scroggs, Pharm.D., Regulatory Project Manager, at
`(301) 827-1250.
`
`
`
`MEDWATCH, HFD-410
`FDA
`5600 Fishers Lane
`Rockville, MD 20857
`
`Sincerely,
`
`
`
`
`{See appended electronic signature page}
`
`
`Brian E. Harvey, M.D., Ph.D.
`Director
`Division of Gastrointestinal and Coagulation Drug Products
`Office of Drug Evaluation III
`Center for Drug Evaluation and Research
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Enclosure:
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`---------------------------------------------------------------------------------------------------------------------
`This is a representation of an electronic record that was signed electronically and
`this page is the manifestation of the electronic signature.
`---------------------------------------------------------------------------------------------------------------------
` /s/
`---------------------
`Joyce Korvick
`7/5/05 04:55:37 PM
`for Dr. Brian E Harvey
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket